(Pro)renin receptor is crucial for Wnt/β-catenin-dependent genesis of pancreatic ductal adenocarcinoma

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Shibayama, Yuki ^a   Fujimori, Takayuki ^a   Nguyen, Genevieve ^b   Hirose, Takuo ^b   Totsune, Kazuhito ^c   Ichihara, Atsuhiro ^d   Kitada, Kento ^a   Nakano, Daisuke ^a   Kobori, Hiroyuki ^a   Kohno, Masakazu ^a   Masaki, Tsutomu ^a   Suzuki, Yasuyuki ^a   Yachida, Shinichi ^a,e   Nishiyama, Akira ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b INSERM   (France)

^c TOHOKU UNIVERSITY   (Japan)

^d TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^e NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATP6AP2 PROTEIN, HUMAN; CELL SURFACE RECEPTOR; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE;

AGED; BLOOD; CARCINOGENESIS; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; PANCREAS; PANCREAS CARCINOMA; PANCREAS TUMOR; TUMOR CELL LINE; VERY ELDERLY; WNT SIGNALING PATHWAY;

AGED; AGED, 80 AND OVER; CARCINOGENESIS; CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREAS; PANCREATIC NEOPLASMS; RECEPTORS, CELL SURFACE; VACUOLAR PROTON-TRANSLOCATING ATPASES; WNT SIGNALING PATHWAY;

EID: 84924359457     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep08854     Document Type: Article

References (43)

1. Duffy, M. J. et al. Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report. Ann Oncol 21, 441-447 (2010).
2. Vincent, A., Herman, J., Schulick, R., Hruban, R. H. & Goggins, M. Pancreatic cancer. Lancet 378, 607-620 (2011).
3. Campbell, P. J. et al. The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature 467, 1109-1113 (2010).
4. Yachida, S. et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467, 1114-1117(2010).
5. Logan, C. Y. & Nusse, R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20, 781-810 (2004).
6. Clevers, H. Wnt/beta-catenin signaling in development and disease. Cell 127, 469-480 (2006).
7. Fodde, R. & Brabletz, T. Wnt/beta-catenin signaling in cancer stemness and malignant behavior. Curr Opin Cell Biol 19, 150-158 (2007).
8. Al-Aynati, M. M., Radulovich, N., Riddell, R. H. & Tsao, M. S. Epithelial-cadherin and beta-catenin expression changes in pancreatic intraepithelial neoplasia. Clin Cancer Res 10, 1235-1240 (2004).
9. Arensman, M. D. et al. WNT7B mediates autocrine Wnt/beta-catenin signaling and anchorage-independent growth in pancreatic adenocarcinoma. Oncogene 33, 899-908 (2013).
10. Yu, M. et al. RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis. Nature 487, 510-513 (2012).
11. Zeng, G. et al. Aberrant Wnt/beta-catenin signaling in pancreatic adenocarcinoma. Neoplasia 8, 279-289 (2006).
12. Heiser, P. W. et al. Stabilization of beta-catenin induces pancreas tumor formation. Gastroenterology 135, 1288-1300 (2008).
13. Pasca di Magliano, M. et al. Common activation of canonical Wnt signaling in pancreatic adenocarcinoma. PLoS One 2, e1155 (2007).
14. Zhang, Y. et al. Canonical Wnt Signaling Is Required for Pancreatic Carcinogenesis. Cancer Res 73,4909-4922 (2013).
15. Biankin, A. V. et al. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature 491, 399-405 (2012).
16. Abraham, S. C. et al. Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations. Am J Pathol 160, 1361-1369 (2002).
17. Gerdes, B. et al. Analysis of beta-catenin gene mutations in pancreatic tumors. Digestion 60, 544-548 (1999).
18. Morris, J. P. T.,Wang, S. C. & Hebrok, M. KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma. Nat Rev Cancer 10, 683-695 (2010).
19. Seymour, A. B. et al. Allelotype of pancreatic adenocarcinoma. Cancer Res 54, 2761-2764 (1994).
20. Polakis, P. Wnt signaling in cancer. Cold Spring Harb Perspect Biol 4, a008052 (2012).
21. Nguyen, G., Delarue, F., Burckle, C., Bouzhir, L., Giller, T. & Sraer, J. D. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest 109, 1417-1427 (2002).
22. Hirose, T. et al. Association of (pro)renin receptor gene polymorphism with blood pressure in Japanese men: the Ohasama study. Am J Hypertens 22, 294-299 (2009).
23. Cousin, C., Bracquart, D., Contrepas, A., Corvol, P., Muller, L. & Nguyen, G. Soluble form of the (pro)renin receptor generated by intracellular cleavage by furin is secreted in plasma. Hypertension 53, 1077-1082 (2009).
24. Kinouchi, K. et al. The (pro)renin receptor/ATP6AP2 is essential for vacuolar H+-ATPase assembly in murine cardiomyocytes. Circ Res 107, 30-34 (2010).
25. Cruciat, C. M. et al. Requirement of prorenin receptor and vacuolar H+-ATPase-mediated acidification for Wnt signaling. Science 327, 459-463 (2010).
26. Buechling, T. et al. Wnt/Frizzled signaling requires dPRR, the Drosophila homolog of the prorenin receptor. Curr Biol 20, 1263-1268 (2010).
27. Hermle, T., Saltukoglu, D., Grunewald, J., Walz, G. & Simons, M. Regulation of Frizzled-dependent planar polarity signaling by a V-ATPase subunit. Curr Biol 20, 1269-1276 (2010).
28. Hruban, R. H., Maitra, A. & Goggins, M. Update on pancreatic intraepithelial neoplasia. Int J Clin Exp Pathol 1, 306-316 (2008).
29. Rulifson, I. C. et al. Wnt signaling regulates pancreatic beta cell proliferation. Proc Natl Acad Sci U S A 104, 6247-6252 (2007).
30. Yun, M. S., Kim, S. E., Jeon, S. H., Lee, J. S. & Choi, K. Y. Both ERK and Wnt/beta-catenin pathways are involved in Wnt3a-induced proliferation. J Cell Sci 118, 313-322 (2005).
31. Song, K. S. et al. Omega-3-polyunsaturated fatty acids suppress pancreatic cancer cell growth in vitro and in vivo via downregulation of Wnt/Beta-catenin signaling. Pancreatology 11, 574-584 (2011).
32. van Noort, M., Meeldijk, J., van der Zee, R., Destree, O. & Clevers, H. Wnt signaling controls the phosphorylation status of beta-catenin. J Biol Chem 277, 17901-17905 (2002).
33. Hotz, M. A., Gong, J., Traganos, F. & Darzynkiewicz, Z. Flow cytometric detection of apoptosis: comparison of the assays of in situ DNA degradation and chromatin changes. Cytometry 15, 237-244 (1994).
34. Hernandez, A. R., Klein, A. M. & Kirschner, M. W. Kinetic responses of beta-catenin specify the sites of Wnt control. Science 338, 1337-1340 (2012).
35. Oshima, Y. et al. Prorenin receptor is essential for normal podocyte structure and function. J Am Soc Nephrol 22, 2203-2212 (2011).
36. Riediger, F. et al. Prorenin receptor is essential for podocyte autophagy and survival. J Am Soc Nephrol 22, 2193-2202 (2011).
37. van Amerongen, R. & Berns, A. Knockout mouse models to study Wnt signal transduction. Trends Genet 22, 678-689 (2006).
38. Zhong, Y. et al. GATA6 activates Wnt signaling in pancreatic cancer by negatively regulating the Wnt antagonist Dickkopf-1. PLoS One 6, e22129 (2011).
39. Watanabe, N. et al. Soluble (pro)renin receptor and blood pressure during pregnancy: a prospective cohort study. Hypertension 60, 1250-1256 (2012).
40. Hirose, T. et al. Gene expression of (pro)renin receptor is upregulated in hearts and kidneys of rats with congestive heart failure. Peptides 30, 2316-2322 (2009).
41. Takahashi, K. et al. Expression of (pro)renin receptor in human kidneys with end-stage kidney disease due to diabetic nephropathy. Peptides 31, 1405-1408 (2010).
42. Tward, A. D. et al. Distinct pathways of genomic progression to benign and malignant tumors of the liver. Proc Natl Acad Sci U S A 104, 14771-14776 (2007).
43. Shibayama, Y. et al. Role of (pro)renin receptor in Ang II-mediated EGF receptor transactivation. Front Biosci (Elite Ed) 5, 697-705 (2013).